Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid vs Vancomycin/Oxacillin/Dicloxacillin for Catheter-Related Gram-Positive Bloodstream Infections
NCT00037050Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of linezolid in catheter-related bloodstream infection (CRBSI), sponsored by Pfizer. Started Apr 2002; status: completed.
02
Drugs
linezolid
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00037050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037050.